U080 Herpes Zoster: Controversies and Conundrums in Treatment and Prevention
DESCRIPTION
In case-based form, herpes zoster case scenarios will be examined using viral mechanistic and clinical clues and updated prevention and treatment guidelines.
LEARNING OBJECTIVES
Summarize the pathogenesis and key clinical features of herpes zoster, including unique presentations in special patient populations.
Identify the best treatment regimens for herpes zoster based on recent literature, including evidence for and against measures to manage post-herpetic neuralgia.
Outline, using case scenarios, systems-based prevention strategies for herpes zoster in health care institutions, including updated vaccination guidelines and hospital isolation policies.
SCHEDULE
4:30 PM
Introduction
Lorraine L. Rosamilia, MD, FAAD
4:35 PM
Zoster diagnostic and treatment options
Whitney A. High, MD, JD, FAAD
4:50 PM
Zoster in special populations
Kieron S. Leslie, MBBS
5:05 PM
Zoster vaccination
Stephen K Tyring, MD, PhD, FAAD
5:20 PM
Zoster clinical cases
Lorraine L. Rosamilia, MD, FAAD
DIRECTOR
Lorraine L. Rosamilia, MD, FAAD
SPEAKERS
Whitney A. High, MD, JD, FAAD
Kieron S. Leslie, MBBS
Stephen K Tyring, MD, PhD, FAAD
DISCLOSURES
Whitney A. High, MD, JD, FAAD
No financial relationships exist with ineligible companies.
Kieron S. Leslie, MBBS
No financial relationships exist with ineligible companies.
Lorraine L. Rosamilia, MD, FAAD
No financial relationships exist with ineligible companies.
Stephen K Tyring, MD, PhD, FAAD
AbbVie – Investigator(Grants/Research Funding), Speaker(Grants/Research Funding); Agenus Inc. – Investigator(Grants/Research Funding); AiCuris GmbH & Co. KG – Investigator(Grants/Research Funding); Almirall – Investigator(Grants/Research Funding); Amgen – Investigator(Grants/Research Funding); Bayer – Consultant(Honoraria), Investigator(Grants/Research Funding); BMS – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria), Investigator(Grants/Research Funding); Demira – Investigator(Grants/Research Funding); Dr Reddy's Laboratory – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); Foamix Pharmaceuticals Ltd – Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding); Genocea Biosciences – Investigator(Grants/Research Funding); GlaxoSmithKline – Speaker(Honoraria); Glenmark Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); IQVIA – Investigator(Grants/Research Funding); Janssen Research & Development, LLC – Investigator(Grants/Research Funding); Kiniksa Pharmaceuticals, Ltd. – Investigator(Grants/Research Funding); LEO Laboratories Ltd (LEO Pharma) – Investigator(Grants/Research Funding); Menlo Therapeutics Inc. – Investigator(Grants/Research Funding); Merck & Co., Inc – Investigator(Grants/Research Funding); Novartis – Investigator(Grants/Research Funding); Nycomed Amersham – Investigator(Grants/Research Funding); Parexel – Investigator(Grants/Research Funding); Quintiles Pharma – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Trevi Therapeutics – Investigator(Grants/Research Funding); UCB – Investigator(Grants/Research Funding); Vical Incorporated – Investigator(Grants/Research Funding);